Population pharmacokinetics and exposure-response relationship of trastuzumab and bevacizumab in early-stage breast cancer
{{output}}
Aims: To describe the sources of interindividual variability of bevacizumab and trastuzumab pharmacokinetics in early-stage breast cancer, and to study the relationship between exposure and both early clinical response and specif... ...
